Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 12 December

Grady Wulff
December 12, 2023

Morning Bell 11 December

Grady Wulff
December 11, 2023

Weekly Wrap 8 December

Sophia Mavridis
December 8, 2023

Morning Bell 8 December

Sam Kanaan
December 8, 2023

Morning Bell 7 December

Sophia Mavridis
December 7, 2023

Morning Bell 6 December

Sam Kanaan
December 6, 2023

Morning Bell 5 November

Grady Wulff
December 5, 2023

Morning Bell 4 December

Sam Kanaan
December 4, 2023

Weekly Wrap 1 December

Grady Wulff
December 1, 2023

Morning Bell 1 December

Sam Kannan
December 1, 2023

Morning Bell 30 November

Sophia Mavridis
November 30, 2023

Morning Bell 29 November

Grady Wulff
November 29, 2023